Onconetix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	4.55	25.75	1.93	4.31	6.05
Cash & Cash Equivalents	4.55	25.75	1.93	4.31	6.05
Cash Growth	-82.32%	1235.39%	-55.24%	-28.79%	-
Receivables	0.15	0.04	0.15	0.04	0.01
Inventory	0.36	0	0	0	0
Other Current Assets	0.77	0.47	0.99	0.24	0
Total Current Assets	5.84	26.26	3.07	4.6	6.06
Property, Plant & Equipment	0.21	0.01	0.01	0.02	0.01
Goodwill and Intangibles	81.09	0	0	0	0
Other Long-Term Assets	0.38	0.04	0	0.2	0.02
Total Long-Term Assets	81.68	0.05	0.01	0.22	0.02
Total Assets	87.52	26.31	3.08	4.81	6.08
Accounts Payable	5.3	1.5	0.58	0.07	0.02
Current Debt	9.69	0	0	0	0
Other Current Liabilities	2.2	2.42	1.06	0	0.06
Total Current Liabilities	17.19	3.92	1.64	0.07	0.08
Long-Term Debt	0.19	0	0	0	0
Other Long-Term Liabilities	4.49	0	0	0.01	0.01
Total Long-Term Liabilities	4.69	0	0	0.01	0.01
Total Liabilities	21.88	3.92	1.64	0.08	0.08
Total Debt	9.89	0	0	0	0
Retained Earnings	-56.79	-19.38	-5.96	-2.54	-0.94
Comprehensive Income	2.38	0	0	0	0
Shareholders' Equity	-5.6	22.39	1.45	4.73	6
Net Cash / Debt	-5.33	25.75	1.93	4.31	6.05
Net Cash / Debt Growth	-	1235.39%	-55.24%	-28.79%	-
Net Cash Per Share	-0.31	2.10	0.60	1.35	1.89
Working Capital	-11.35	22.34	1.44	4.53	5.98
Book Value Per Share	-0.33	1.82	0.45	1.48	1.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).